Preservatives News and Research

RSS

Neuroptis Biotech reports positive results from ML7 preclinical trials for eye surface diseases

Neuroptis Biotech, the ophthalmology drug research and development specialist, announces positive results in preclinical trials of the eye-drop formulation of its ML7 product. ML7 is intended for use in the treatment of eye surface diseases, particularly dry eye.

13 Nov 2013

Common food additive can block new strain of avian influenza virus

A common food additive can block a deadly new strain of avian influenza virus from infecting healthy cells, report researchers at the University of Illinois at Chicago College of Medicine in the online journal, PLOS ONE.

24 Oct 2013

Paragon BioTeck, Horus Pharma sign distribution agreement for Ilast range of products

Paragon BioTeck, Inc. today announced that it has signed a distribution agreement with Horus Pharma for rights to supply the Ilast range of its medical-grade ocular hygiene and lid care products within the United States; it begins on an exclusive basis this month.

10 Oct 2013

Retinitis pigmentosa test identifies mutation found in Ashkenazi Jewish population

You might not think to look to a urine test to diagnose an eye disease. But a new Duke University study says it can link what is in a patient's urine to gene mutations that cause retinitis pigmentosa, or RP, an inherited, degenerative disease that results in severe vision impairment and often blindness. The findings appear online in the Journal of Lipid Research.

9 Oct 2013

Dog food preservative may prevent nerve damage in patients taking chemotherapy

Working with cells in test tubes and in mice, researchers at Johns Hopkins have discovered that a chemical commonly used as a dog food preservative may prevent the kind of painful nerve damage found in the hands and feet of four out of five cancer patients taking the chemotherapy drug Taxol.

20 Sep 2013

New Atkins Candies help dieters satisfy their sweet tooth with low-carb option

Low-carb dieters now have an even sweeter way to melt off the pounds. Atkins Nutritionals, Inc., a leader in the weight-management category, announced today the launch of Atkins™ Candies, an indulgent line of bite-sized snacks that will be available nationwide beginning October 2013.

10 Sep 2013

Altaire Pharmaceuticals recalls 9 lots of Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution

Altaire Pharmaceuticals, Inc., announces today that it is voluntarily recalling a total of nine (9) lots of Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution, 30 mL, to the consumer level. There have been no reports of adverse effects to consumers so far.

7 Sep 2013

Kate Farms announces personal endorsement deals with two professional athletes

Kate Farms, the creator of Komplete Ultimate Shakes, is excited to announce personal endorsement deals with professional auto racing driver,Tristan Nunez and undefeated professional boxer, Gabino Saenz. Komplete is the world's first vegan, dairy-free, gluten-free and soy-free ready to go drink meal replacement shake available in three flavors including Vanilla Bliss, Cocoa Fudge and Jav'a Latte and can be purchased nationally at The Vitamin Shoppe.

31 Aug 2013

Genetic analysis of intestinal bacteria shows Danes have 40% less gut bacteria genes

All people have trillions of bacteria living in their intestines. If you place them on a scale, they weigh around 1.5 kg. Previously, a major part of these 'blind passengers' were unknown, as they are difficult or impossible to grow in laboratories.

29 Aug 2013

Novartis starts shipment of 2013-2014 seasonal influenza vaccines to US customers

Novartis announced today that it has begun shipment of its seasonal influenza vaccines to customers in the US market for the 2013-2014 season. Novartis plans to ship a minimum of 30 million doses of its influenza vaccines to the US market, including Fluvirin (Influenza Virus Vaccine), approved for use in people 4 years of age and older, and Flucelvax (Influenza Virus Vaccine), approved for use in adults 18 years of age and older.

22 Aug 2013

Symptoms and treatment for facial allergic contact dermatitis

Facial rashes can take on many forms. Whether red, flat, bumpy and dry, or scaly, flaky and itchy, the appearance of a rash on the face can be very distressing.

3 Aug 2013

Novaliq receives CE mark approval for EyeSol technology

Novaliq GmbH, a drug delivery company with a focus on the topical application of ophthalmic technologies for poorly soluble drugs, today announced the successful CE mark approval for the first topical eye lubricant based on Novaliq's proprietary technology EyeSol.

23 Jul 2013

Report alerts clinicians, public about catastrophic dangers of contaminated epidural injections

Investigators from the Centers for Disease Control and Prevention describe pathologic findings from 40 case reports of fungal infection in patients who had been given contaminated epidural, paraspinal, or intra-articular (into joints) steroid injections and correlate these findings with clinical and laboratory data.

26 Jun 2013

FDA recommends health care providers not to administer steroid injections from Main Street

The U.S. Food and Drug Administration is working closely with the Centers for Disease Control and Prevention and Tennessee Board of Pharmacy to investigate reports of seven adverse events associated with steroid injections compounded by Main Street Family Pharmacy, LLC (Main Street) of Newbern, Tenn.

26 May 2013

Mercury conference in Edinburgh to confront contentious topics

One of the panel sessions at the ‘Mercury 2013’ International Conference in Edinburgh (28th July – 2nd Aug) “will be highly contentious and should result in a heated debate,” says Prof. K. Clive Thompson who will be chairing the session with Eric Uram from SafeMinds.

24 May 2013

Transfusion of older blood adversely affects patients undergoing cardiac surgery or critical care

Transfusion of donated blood more than three weeks old results in impaired blood vessel function, a new study of hospital patients shows.

11 Mar 2013

140 nations adopt treaty to reduce mercury emissions; Convention will allow use of mercury preservative in vaccines

"More than 140 nations adopted the first legally binding international treaty on Saturday aimed at reducing mercury emissions, after four years of negotiations on ways to set limits on the use of a highly toxic metal," the Associated Press/New York Times reports.

22 Jan 2013

Ban on thiomersal in vaccines would harm global immunization efforts

"Government representatives are meeting in Geneva this week to decide whether to introduce a global ban on mercury that could include thiomersal, a mercury-based preservative that has been used in some vaccine manufacturing since the 1930s to prevent bacterial or fungal contamination of multidose vials of vaccine," Seth Berkley, a medical epidemiologist and chief executive of the GAVI Alliance, writes in a New York Times opinion piece.

19 Jan 2013

GE Healthcare submits Optison sNDA to aid in detection of cardiovascular diseases

GE Healthcare today announced that it has filed a supplemental new drug application (sNDA) that will allow the company to manufacture Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), within its own facility.

16 Jan 2013

Experts question proposed mercury preservative ban in vaccines

A ban on the use of a mercury-based preservative in vaccines tabled by the United Nations Environmental Program should be struck from a draft treaty as it may severely affect access to vaccines, experts urge.

4 Jan 2013